Laboratory Medicine ›› 2016, Vol. 31 ›› Issue (1): 17-21.DOI: 10.3969/j.issn.1673-8640.2016.01.004

• Orginal Article • Previous Articles     Next Articles

Longitudinal study on fibrinolytic activity changes during normal pregnancy for hypercoagulation

WANG Yuefang, SHI Hua, YUE Xinai, JIANG Yongmei   

  1. Department of Clinical Laboratory,West China Second University Hospital,Sichuan University,Chengdu 610041,Sichuan,China
  • Received:2015-05-14 Online:2016-01-31 Published:2016-02-16

Abstract:

Objective To investigate the changes of fibrinolytic activity during normal pregnancy for hypercoagulation in Chinese Han population. Methods A total of 100 healthy pregnant women(healthy pregnant group) and 100 healthy unpregnant women(unpregnant control group) were enrolled in the longitudinal study. Fibrinogen(Fg),fibrin degradation product(FDP),Fg/FDF ratio,tissue-type plasminogen activator(t-PA),plasminogen activator inhibitor -1(PAI-1) and t-PA/PAI-1 ratio were evaluated. The correlations of Fg and FDP with t-PA/PAI-1 were analyzed. Results Fg,FDP and Fg/FDP ratio increased with the period of pregnancy(P<0.01). Compared with unpregnant control group,t-PA,PAI-1 and t-PA/PAI-1 ratio increased in healthy pregnant group(P<0.05). t-PA/PAI-1 ratio and Fg were positively related during early pregnancy [correlation coefficient (r)=0.81,P<0.05],and t-PA/ PAI-1 ratio was the lowest during middle pregnancy(the degradation rate of Fg was the lowest). Fg increased significantly during late pregnancy and reached the highest level. The correlation between t-PA/PAI-1 ratio and FDP was positive during early and late pregnancy(r=0.75 and 0.79,P<0.05). Conclusions In Chinese Han population,their bodies do not trigger coagulation during normal pregnancy. The bodies controls directly elevated Fg by increasing primary fibrinolytic activity,and coagulation / fibrinolysis system maintains balance on high level .

Key words: Fibrinolysis system, Pregnancy, Fibrinogen, Tissue-type plasminogen activator, Plasminogen activator inhibitor-1

CLC Number: